chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Woke up with visual spinning to the left, in standing resulted in right sided loss of balance backwards. Unable to make symptoms better or worse. I contemplated going to the ER due to possible CVA although I did not have any classic CVA symptoms. I called my PCP who recommended I come in to the clinic: waited 3  hrs with symptoms unchanged. They performed an EKG (improperly) it was negative, some form of EEG (that was later denied by the insurance) also negative, received a head CT next the day it was negative.   Visual symptoms of impaired gaze stability persist to this day. Ophthalmologist ordered MRI with special focus to inner ear and it was negative. I am currently still seeing an optometrist for vision therapy.
I still have a sore lymph node in armpit on side vaccine was given all these months later. I got the bivalent vaccine also, but the sore lymph node started with the booster noted in this form.
Fever 7pm 11/15/21 ending 10am 11/17/21. High 101 midday 11/16/21.  Chills, lower leg muscle aches and feeling of shin splints both legs-joint pain knees ,left hip, shoulders -headache-nausea night of 11/15/21 subsided by next morning except headache. Pounding rapid heartbeat night of 11/15/21 subsided Eve 11/16/21. Blurry vision 11/16/21 subsided completely 11/19/21. Tarry stool 11/16/21.red hot area below injection site @6? circumference started day after. Ongoing and started to itch 4 days after.  Some sinus /ear congestion day 3  -subsided
swelling of mouth, tongue and gums (resolved in 5 days) ; "pins and needles throughout body including face" (resolved in 5 days); swelling in lymph nodes (greater swelling on vaccination side), resolved in 9 days.  Reported to Dr. to confirm no known interaction with Trulicity.
flu symptoms after my second original Covid vaccination; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program. The reporter is the patient.  A 66 year-old male patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose 1), for COVID-19 Immunization. The following information was reported: INFLUENZA (non-serious), outcome "unknown", described as "flu symptoms after my second original Covid vaccination".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
The evening of June 9th 2021 I woke up around 2 am with the worst leg pain both legs . Woke me out of a dead sleep that was night 1 , the following day I had a full headache right side of my head pain behind my eye, temple and a throbbing in my sinuses. Took Tylenol and delt with it . The following day after that , the headache was still there but getting worse, ibuprofen and tried to rest. This continued the pain in the same location .. we are now day 6 pain got to the point of unbearable no matter what I tried to bring relief, burning in the center of my chest and left leg pain... over the counter meds are not working .. I went to my clinic where I was given  information to report this even and then transferred to hospital so they could do a brain scan checking for bleeding and or clots. Nothing was found . Saying maybe vaccine sent me into a cluster migraine? Gave me some more medicine but so far that is not working either I am home now hoping and praying this ends soon .. this pain is excruciating this was my second shot from  Pfizer .
Information has been received from a registered nurse concerning a 15 year old female patient who on an unknown date was vaccinated IM with a first 0.5ml dose of Gardasil. After receiving the dose, the patient fainted. Laboratory diagnostic studies included a c-spine x-ray that was reported as normal. Subsequently, the patient recovered. No product quality complaint was involved. This is one of two reports from the same source. Additional information has been requested.
Booster; Mild fever; Pain at injection site; Tiredness; Headache; Overall muscle aches; Chills; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 31 year-old male patient received bnt162b2 (BNT162B2), intramuscular, administered in arm left, administration date 01Dec2021 09:45 (Lot number: FH8027) at the age of 31 years as dose 3 (booster), single for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. Vaccination history included: Bnt162b2 (Prev dose Product: COVID 19, Prev dose Brand: Pfizer, Prev dose Lot number: EL3247, Prev dose Administrator route: Intramuscular, Prev dose Vaccine location: Left arm, Prev dose Dose number: 2), administration date: 19Feb2021, when the patient was 30 years old, for COVID-19 Immunization; Bnt162b2 (Prev dose Product: COVID 19, Prev dose Brand: Pfizer, Prev dose Lot number: EL3247, Prev dose Administrator route: Intramuscular, Prev dose Vaccine location: Left arm, Prev dose Dose number: 1), administration date: 29Jan2021, when the patient was 30 years old, for COVID-19 Immunization. The following information was reported: IMMUNISATION (non-serious) with onset 01Dec2021 20:00, outcome "recovering", described as "Booster"; PYREXIA (non-serious) with onset 01Dec2021 20:00, outcome "recovering", described as "Mild fever"; VACCINATION SITE PAIN (non-serious) with onset 01Dec2021 20:00, outcome "recovering", described as "Pain at injection site"; FATIGUE (non-serious) with onset 01Dec2021 20:00, outcome "recovering", described as "Tiredness"; HEADACHE (non-serious) with onset 01Dec2021 20:00, outcome "recovering", described as "Headache"; MYALGIA (non-serious) with onset 01Dec2021 20:00, outcome "recovering", described as "Overall muscle aches"; CHILLS (non-serious) with onset 01Dec2021 20:00, outcome "recovering", described as "Chills". Therapeutic measures were taken as a result of immunisation, pyrexia, vaccination site pain, fatigue, headache, myalgia, chills.  Additional information: The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine.Treatment with Tylenol (OTC) received for the adverse event.Prior to vaccination, was the patient was not diagnosed with COVID-19.Since the vaccination, has the patient been tested for COVID-19.  No follow-up attempts are possible. No further information is expected.
Severe sharp on going chest pain, sharp pain when breathing the night after the vaccine. Heart beating abnormally- as heart beats fast and slows down such as a palpitation. Sharp chest pain has not subsided and it has been almost a month. No treatment has been done- solely prescription of ibprofen which at this time does not subside the chest pain. Sleeping in difficult as the chest hurts throughout the night.
5 MINUTES POST-VACCINATION PATIENT FELT DIZZY, LIGHT HEADEDNESS, LETHARGIC, PALE TREATMENT: TRIED CHECKING BLOOD PRESSURE, LAID FLAT ON FLOOR, ELEVATED HIS LEGS OUTCOME: PATIENT WAS EVALUATED BY PARAMEDICS, WENT TO THE ER FOR FURTHER TRIAGE BUT DID NOT RECEIVE FURTHER TREATMENT, PATIENT SENT HOME`
This spontaneous report was received from a medical assistant and refers to unspecified patients of unknown age and gender. No information about the patients's medical history, concurrent conditions and concomitant therapies was provided. On unknown dates, the patients were vaccinated with a dose of improperly stored PROQUAD lot # L051100, expiration date: 17-JUN-2017, albumin status: rHA (dose and route of administration were not reported) and lot# M007964, expiration date: 15-AUG-2017, albumin status: rHA (dose and route of administration were not reported). Temperature excursion lasted 8 hours and temperature decreased to 6 Fahrenheit degrees. Data logger and product quality complaint were not involved. No adverse effect was reported. This is one of several reports received from the same reporter. Additional information has been requested. Sender's Comments: US-009507513-1612USA008912.
pt states approx 2 days p/vax noted the upper area of lt arm was swollen & was itchy;no n/v/d/h/a, dizziness;pt states was also sore;
Can barely swallow; her glands are huge; Cough; congestion; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  An adolescent female patient (not pregnant) received bnt162b2 (BNT162B2), administration date Oct2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. Relevant medical history included: "Lyme's disease" (unspecified if ongoing); "Known allergies: peanuts" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: DYSPHAGIA (non-serious) with onset 14Oct2021, outcome "not recovered", described as "Can barely swallow"; LYMPHADENOPATHY (non-serious) with onset 14Oct2021, outcome "not recovered", described as "her glands are huge"; COUGH (non-serious) with onset 14Oct2021, outcome "not recovered", described as "Cough"; NASAL CONGESTION (non-serious) with onset 14Oct2021, outcome "not recovered", described as "congestion". The events "can barely swallow", "her glands are huge", "cough" and "congestion" were evaluated at the physician office visit. Relevant laboratory tests and procedures are available in the appropriate section. It was unknown if therapeutic measures were taken as a result of dysphagia, lymphadenopathy, cough, nasal congestion.  Additional information: the patient did not have Covid prior to vaccination. The patient was tested for covid post vaccination.  No follow-up attempts are possible. No further information is expected.
vaccines were left in a cooler for 7 days max temp 68F , no AE; Initial information received on 23-Jul-2020 regarding an unsolicited valid non-serious case received from a other health professional.  This case involves Adult female patient which was IPV (VERO) [IPOL] (lot R1D973M and expiry date: 17-Jul-2021), DIPHTHERIA-15/TETANUS/5 AC PERTUSSIS VACCINE [DAPTACEL] (lot C5643CA and expiry date: 17-Jul-2021) and HIB (PRP/T) VACCINE [ACT-HIB] (lot UJ138AAB and expiry date: 03-Aug-2021) temperature excursion vaccines were left in a cooler for 7 days max temp 68 farenheit (product storage error).  Medical history, medical treatment, vaccination and family history were not provided.  Concomitant medication was not reported.  This was potential medication error case due to incorrect product storage.   At the time of reporting, it was not reported if the vaccine was not administered or not  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holders compliance with the requirements set out in Directive and Module VI of the Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
needle was placed into the patient's arm and immediately the syringe came off the needle.  All of the vaccine dripped down the patient's arm leaving the needle in his arm.  Patient was redosed
He had signs of a respiratory infection. He didn't want to lay down because he was having difficulty breathing. We took him to the doctor, and they diagnosed him with an ear infection and upper respiratory infection. He tested negative for COVID-19 and flu. They prescribed amoxicillin and when he didn't show improvement, they upped it to AUGMENTIN.
This spontaneous report as received from a consumer reporting on himself who on 15-JUN-2011, was vaccinated with a dose of ZOSTAVAX (dose, route and lot number was not reported). On 18-MAY-2014, the patient experienced was diagnosed with shingles, he went to the emergency room due to pain on the right side of his head. At the time of the report, the patient no longer had any symptoms of shingles. The relatedness for shingles and ZOSTAVAX was unknown. Additional information has been requested.
This initial spontaneous report was received from a third party claims administrator and refers to a female patient of unknown age. Medical history and concomitant medications were not provided. On 26-SEP-2017, the patient was vaccinated with ZOSTAVAX in the left arm at a pharmacy (dose, route and lot # not provided). After the vaccine (exact date not specified), the patient experienced adverse effects: rash, itchy to touch. The outcome of the event was unknown. Causality was assessed as related to ZOSTAVAX. Additional information has been requested.
Expired Havrix administered; This non-serious case was reported by a nurse via call center representative and described the occurrence of expired vaccine used in a patient who received HAV (Havrix) (expiry date DEC-2022) for prophylaxis.   On 12-APR-2023, the patient received Havrix. On 12-APR-2023, an unknown time after receiving Havrix, the patient experienced expired vaccine used (Verbatim: Expired Havrix administered). The outcome of the expired vaccine used was unknown.   Additional Information: GSK receipt date: 12-APR-2023 The reporter consented to follow up.  No additional details provided. The patient received an expired dose of Havrix, which led to expired vaccine used.
pt rcvd vax; pt taken to ER approx 24 hrs after immunizations for inc t & resp. distress;
Initial and follow up information has been received from a pharmacist concerning her daughter, a 31 month old female with no drug allergies and no pertinent medical history who on an unspecified date was vaccinated with the first "standard dose" of VARIVAX (Merck) (LOT # not reported).  On 25-JUL-2009 the patient experienced varicella rashes, it was a full blown chicken pox and it was 10 days since she started to have them.  The patient still had lesions until now.  On 03-AUG-2009 the patient experienced infection.  The patient sought medical attention as her mother is a pharmacist.  It was noted that the patient did not received the second dose of VARIVAX (Merck).  The patient was being treated with acyclovir.  It was noted by the pharmacist that her son, a 5 year old male who received the first dose of VARIVAX (Merck) on an unspecified date, received the second dose on 22-JUL-2009.  The pharmacist thought that since her son received the second dose of VARIVAX (Merck) that might have triggered her daughter to develop chicken pox.  The patient had not recovered at this time.  The patient was enrolled in the Varicella Zoster Virus Identification Program to identify if VZV was present and if it was present, to identify if it was associated with the wild-type (WT) VZV strain or with the Merck vaccine strain.  The specimen was collected on 06-AUG-2009 from back side of right leg and the type was lesion (scab).  The specimen on 07-AUG-2009 had arrived in laboratory.  The VZV DNA and beta-globin DNA were not amplified.  The PCR analysis of the vesicular specimen revealed it was inadequate.  There was "lots of material" but no beta-globin identified.  This is an amended report.  The two terms of "rash vesicular" has been deleted since the patient was diagnosed with chickenpox.  The second to last sentence of the narrative has been updated.  Additional information has been requested.
Received in L upper arm PREVNAR 13 -> developed erythema and warmth at area 7cm x 7cm, approximately 24 hours afterwards - KEFLEX, BENADRYL.
Inappropriate schedule of vaccine; Stage 1 Breast Cancer; This case was reported by a consumer via call center representative and described the occurrence of breast cancer stage i in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included Herpes zoster (Shingrix) for prophylaxis.   In September 2018, the patient received the 1st dose of Shingrix. On an unknown date, the patient received the 2nd dose of Shingrix. In November 2018, between 2 and 3 months after receiving Shingrix and not applicable after receiving Shingrix, the patient experienced breast cancer stage i (serious criteria GSK medically significant). On an unknown date, the patient experienced incomplete course of vaccination. The patient was treated with chemotherapy, nos (Chemotherapy). On an unknown date, the outcome of the breast cancer stage i and incomplete course of vaccination were unknown.   It was unknown if the reporter considered the breast cancer stage i to be related to Shingrix.  Additional details were provided as follows: The patient reported for herself. The age at vaccination was not provided. The patient diagnosed with Stage 1 breast cancer when she went for her routine mammogram. She went through chemotherapy. Now, the patient's blood test and all the results were normal. The patient was late for her 2nd dose and till the time of reporting she did not receive it, which led to incomplete course of vaccination. No further details were provided.      Lab Comments: On an unknown date, blood test was performed
It's like brittles on my back through my shoulder blade; Chills; My muscles aching; It hurts my lower back; I am tired; This is a spontaneous report from contactable consumer (patient).  This 48-years-old male patient received the first dose of bnt162b2 (PFIZER BIOTECH COVID-19 VACCINE, Batch/Lot Number: ER8733), via an unspecified route of administration, administered in Arm Left on 26Mar2021 as single dose for covid-19 immunisation. There has no medical history or concomitant medications. On 26Mar2021, the patient reported it's like brittles on his back through his shoulder blade. The patient had chills and his muscles aching. It hurts his lower back and he was tired. The outcome of the events was not recovered/not resolved..
patient had itchy rash with small, raised bumps develop all over her arm (not the arm she received the vaccine in)/ some itchy spots starting to develop on her knee, similar to those on her arm.; Some of these spots grew into larger welts; scars; stiff neck, worse than she has ever experienced before,; raised bumps develop all over her arm (not the arm she received the vaccine in).; This is a spontaneous report from a contactable consumer (patient). A 5-decade-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on an unspecified date as dose 1, single for COVID-19 immunization. The patient medical history and concomitant medications were not reported. Approximately 6 days after receiving the first dose of the Pfizer vaccine the patient had itchy rash with small, raised bumps develop all over her arm (not the arm she received the vaccine in). Some of these spots grew into larger welts and have left scars. Vaccination was received approximately one month ago. Patient also reported a very stiff neck, worse than she has ever experienced before, days after receiving the vaccine. On the day patient reported this to me, she also noticed some itchy spots starting to develop on her knee, similar to those on her arm. Patient did go see her doctor about these skin issues after receiving vaccine and received a steroid cream which patient reported did not help very much. A dose of oral steroid did help some. She has not received the second dose of the vaccine and is unsure if she will at this time. The outcome of the events was unknown.  The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.  Follow up (01Oct2021): This follow-up is being submitted to notify that the lot/batch number is not available despite the follow-up attempts made. Follow-up attempts completed. No further information is expected.
Pain to the touch and redness to deltoid area of left arm. Patient concerned it is infected. He was not angry, just concerned. I urged him to see a doctor immediately. I let him know I was reporting it. Patient made appointment with Dr. and the Dr. said that it was not infected, it was just a reaction to the vax (Fluad 2023). Prescribed Triamcinolone 0.1% cream twice daily. Pt saw Dr., who stated that it was a reaction to the flu shot, Fluad. A note was added to his profile that there was an allergic reaction to Fluad. Patient called me on 9/14/23 @ 10:20AM and stated his arm is improved and not as red or swollen.
Redness rash, on (L) arm. Preferred of MD visit appt vs ER. Went to ER. Cancelled appt 12/19/18. N/S (no show appt) 12/20/18.
Headache, Rash, UrticariaPruritus, Nausea Vomiting, erythematous rash over left arm with itching after 2 days of vaccination Narrative:
Off and on since 1st injection lasting minutes to hours: numbness in arm, inability to make a fist, arm feels limp/heavy, pinching, burning sensation from injection site down.
Patient was given vaccine, 15 min after receiving the vaccine the patient experienced SOB. Pt stated she has anxiety and asthma.  I was going to give her an EPI pen but she denied it. Said she was fine and it was her asthma. I asked if she was experiencing tightness in her chest/throat. She stated no and there was no signs of rash or swelling. Patient took her inhaler and was given water. She was monitored for 15 more min and was fine.
I had an appendix removal at an age outside of the normal range.  Had my appendix removed 5/5/21
He had severe diarrhea and also vomiting and also he was taken to the hospital; He had severe diarrhea and also vomiting and also he was taken to the hospital; Abdominal pain; Severe skin sensitivity; loss some weight; Chills; This is a spontaneous report received from a contactable reporter (Consumer or other non HCP), Program ID. The reporter is the patient.  A 63-year-old patient received BNT162b2 (BNT162B2), on 05Aug2022 as dose 4 (booster), single (Lot number: FP7138, Expiration Date: Dec2022) at the age of 62 years for COVID-19 immunisation. The patient's relevant medical history was not reported. Concomitant medication included: FLOMAX [TAMSULOSIN HYDROCHLORIDE]. Vaccination history included: COVID -19 vaccine (dose 1, single, Manufacturer unknown), for COVID-19 immunization; COVID -19 vaccine (dose 2, single, Manufacturer unknown), for COVID-19 immunization; COVID -19 vaccine (dose 3, single, Manufacturer unknown), for COVID-19 immunization. The following information was reported: VOMITING (hospitalization), DIARRHOEA (hospitalization), outcome "unknown" and all described as "He had severe diarrhea and also vomiting and also he was taken to the hospital"; ABDOMINAL PAIN (non-serious), outcome "unknown"; HYPERAESTHESIA (non-serious), outcome "unknown", described as "Severe skin sensitivity"; WEIGHT DECREASED (non-serious), outcome "unknown", described as "loss some weight"; CHILLS (non-serious), outcome "unknown". The patient underwent the following laboratory tests and procedures: Weight: loss. Clinical course details: Patient had severe diarrhea and vomiting so he was taken to the hospital. Patient stated he stayed 5 days of the week in intensive care. Patient was told that those were the side effects until he started to have abdominal pain, severe skin sensitivity, chills and everything. Patient was trying to get back to normal. He was drinking dairy then similar products. He was trying to eat very less and Wednesday morning (date unspecified) when his nephew found out and took him to hospital. Patient had 4 vaccines. Patient stated he may have loss some weight in the hospital.
I received my 4th Moderna Booster on 06/21/2022. My COVID-19 symptoms started on 09/25/2022 around 12:00PM in the afternoon. I had a sore throat, and a headache. I did a COVID-19 home test around 05:00PM which was positive. I called the tele doc the next day he prescribed me with PAXLOVID for 5 days. I also took ibuprofen and NYQUIL as per needed.
Blurred vision, difficulty breathing (pale skin/blue lips), profuse sweating, muscle fatigue, headache. This lasted about 15 minutes. Until severity went down. Followed by 20 minutes of profuse sweating and headache.  I thought I was going to die
Pt developed varicella rash at age 6 11/12 yr after receiving varicella vaccine at age 1 yr. Pt. with 20 spots, vesicles, itch, temp increased 101 2 days. Pt 111 7+ days.